1,665
Views
21
CrossRef citations to date
0
Altmetric
Editorial

Impact of acute lymphoblastic leukemia therapy on attention and working memory in children

&
Pages 655-659 | Published online: 10 Jan 2014

References

  • Pui CH, Campana D, Pei D et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med.360(26), 2730–2741 (2009).
  • Jansen NC, Kingma A, Schuitema A et al. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study. Eur. J. Cancer42, 2765–2772 (2006).
  • Buizer AI, De Sonneville LMJ, van den Heuvel-Eibrink MM, Veerman AJP. Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer106(9), 2067–2075 (2006).
  • Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr. Rehabil.7(1), 1–14 (2004).
  • Jain N, Brouwers P, Okcu M, Cirino P, Krull KR. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer115(18), 4238–4245 (2009).
  • Campbell LK, Scaduto M, Van Slyke D, Niarhos F, Whitlock JA, Compas B. Executive function, coping, and behavior in survivors of childhood acute lymphocytic leukemia. J. Pediatr. Psychol.34, 317–327 (2008).
  • Schatz J, Kramer JH, Ablin A, Matthay KK. Processing speed, working memory and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology14(2), 189–200 (2000).
  • Peterson CC, Johnson CE, Ramirez LY et al. A meta-analysis of the neuropsyhological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr. Blood Cancer51, 99–104 (2008).
  • Mennes M, Stiers P, Vandenbussche E et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr. Blood Cancer44, 479–486 (2005).
  • Ashford J, Schoffstall C, Reddick WE et al. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer116(19), 4638–4645 (2010).
  • Campbell LK, Scaduto M, Sharp W et al. A meta-analysis of the neurocognitve sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr. Blood Cancer49(1), 65–73 (2007).
  • Smith B. Brain damage after intrathecal methotrexate. J. Neurol. Neurosurg. Psychiatry38(8), 810–815 (1975).
  • Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics6(7), 673–689 (2005).
  • Montour-Proulx I, Kuehn SM, Keene DL et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the pediatric oncology group 9605 protocol. J. Child Neurol.20(2), 129–133 (2005).
  • Krull KR, Brouwers P, Jain N et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J. Pediatr.152, 101–105 (2008).
  • Luciana M, Depue RA, Arbisi P, Leon A. Facilitation of working memory in humans by D2 dopamine receptor agonist. J. Cogn. Neurosci.4, 58–68 (1992).
  • Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry159(4), 652–654 (2002).
  • Diamond A, Briand L, Fossella J, Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am. J. Psychiatry161(1), 125–132 (2004).
  • Reddick WE, Laningham FH, Glass JO, Pui CH. Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia. Neuroradiology49(11), 889–904 (2007).
  • Reddick WE, Glass JO, Helton KJ, Langston JW, Chin-Shang L, Pui CH. A quantitative MRI assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. AJNR Am. J. Neuroradiol.26(9), 2371–2377 (2005).
  • Reddick WE, Glass JO, Helton KJ et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am. J. Neuroradiol.26(5), 1263–1269 (2005).
  • Reddick WE, Shan ZY, Glass JO et al. Smaller white matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer106(4), 941–949 (2006).
  • Carey ME, Haut MW, Reminger SL, Hutter JJ, Theilmann R, Kaemingk KL. Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study. AJNR Am. J. Neuroradiol.29(4), 792–797 (2008).
  • Reddick WE, Glass JO, Johnson DP, Laningham FH, Pui CH. Voxel based analysis of T2 hyperintensities in white matter during treatment for childhood leukemia. AJNR Am. J. Neuroradiol.30(10), 1947–1954 (2009).
  • Mabbott DJ, Noseworthy M, Bouffet E, Laughlin S, Rockel C. White matter growth as a mechanism of cognitive development in children. Neuroimage33(3), 936–946 (2006).
  • Porto L, Preibisch C, Hattingen E et al. Voxel-based morphometry and diffusion-tensor MR imaging of the brain in long-term survivors of childhood leukemia. Eur. Radiol.18, 2691–2700 (2008).
  • Aukema EJ, Caan MWA, Oudhuis N et al. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int. J. Radiat. Oncol. Biol. Phys.74(3), 837–843 (2009).
  • Yamamoto A, Miki Y, Adachi S et al. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy. Eur. Radiol.57(3), 423–427 (2006).
  • Laule C, Vavasour IM, Madler B et al. MR evidence of long T2 water in pathological white matter. J. Magn. Reson. Imaging26, 1117–1121 (2007).
  • Mulhern RK, Khan RB, Kaplan S et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J. Clin. Oncol.22(23), 4743–4751 (2004).
  • Conklin HM, Khan RB, Reddick WE et al. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills and academic abilities of childhood cancer survivors. J. Clin. Oncol.28(29), 4465–4472 (2010).
  • Kohli S, Fisher SG, Tra Y et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer115(12), 2605–2616 (2009).
  • Shaw EG, Rosdhal R, D’Agostino RB Jr et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J. Clin. Oncol.24(9), 1415–1420 (2006).
  • Butler RW, Copeland DR, Fairclough D et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J. Consult. Clin. Psychol.76(3), 367–378 (2008).
  • Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: a pilot project. J. Pediatr. Hematol. Oncol.31(9), 670–677 (2009).
  • Leigh L Conklin HM. Educational issues for children with cancer. In: Principles and Practice of Pediatric Oncology. Pizzo PA, Poplack DO (Eds). JB Lipcott Company, PA, USA (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.